420 results on '"Denis, Cécile V."'
Search Results
2. Type 2N von Willebrand disease: genotype drives different bleeding phenotypes and treatment needs
3. Angiopoietin-2 binds to multiple interactive sites within von Willebrand factor
4. Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy
5. Efficacy of platelet-inspired hemostatic nanoparticles on bleeding in von Willebrand disease murine models
6. A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD
7. ADP receptor P2Y12 is the capstone of the cross-talk between Ca2+ mobilization pathways dependent on Ca2+ ATPases sarcoplasmic/endoplasmic reticulum type 3 and type 2b in platelets
8. Thrombin generation on vascular cells in the presence of factor VIII and/or emicizumab
9. A gain‐of‐function filamin A mutation in mouse platelets induces thrombus instability
10. Antithrombotic potential of a single‐domain antibody enhancing the activated protein C‐cofactor activity of protein S
11. New insights into regulation of αIIbβ3 integrin signaling by filamin A
12. Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis
13. Camelid‐derived single‐chain antibodies in hemostasis: Mechanistic, diagnostic, and therapeutic applications
14. Development and characterization of single‐domain antibodies neutralizing protease nexin‐1 as tools to increase thrombin generation
15. Measuring beta‐galactose exposure on platelets: Standardization and healthy reference values
16. Differences in venous clot structures between hemophilic mice treated with emicizumab versus factor VIII or factor VIIIFc
17. MAGT1 deficiency in XMEN disease is associated with severe platelet dysfunction and impaired platelet glycoprotein N-glycosylation
18. A single‐domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor
19. Targeting protease nexin-1, a natural anticoagulant serpin, to control bleeding and improve hemostasis in hemophilia
20. Disrupted filamin A/αIIbβ3 interaction induces macrothrombocytopenia by increasing RhoA activity
21. The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction
22. Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor
23. A mutation of the human EPHB2 gene leads to a major platelet functional defect
24. IdeS, a new option to optimize the management of patients with hemophilia A on emicizumab
25. NAADP/SERCA3-Dependent Ca2+ Stores Pathway Specifically Controls Early Autocrine ADP Secretion Potentiating Platelet Activation
26. Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?
27. Complex formation with pentraxin-2 regulates factor X plasma levels and macrophage interactions
28. Defect in Regulated Secretion of P-Selectin Affects Leukocyte Recruitment in von Willebrand
29. Macrophage receptor SR-AI is crucial to maintain normal plasma levels of coagulation factor X
30. Impaired platelet activation and cAMP homeostasis in MRP4-deficient mice
31. von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends
32. Von Willebrand factor and cancer: Another piece of the puzzle
33. P.31 Von Willebrand Factor Induces Vascular Smooth Muscle Cell Proliferation and Migration Through Low Density Lipoprotein-Related Receptor Protein 4 and αvβ3 Integrin
34. Impact of PI3Kα (Phosphoinositide 3-Kinase Alpha) Inhibition on Hemostasis and Thrombosis
35. Accelerated uptake of VWF/platelet complexes in macrophages contributes to VWD type 2B–associated thrombocytopenia
36. Identification of von Willebrand factor D4 domain mutations in patients of Afro‐Caribbean descent: In vitro characterization
37. Mutations in the A3 domain of Von Willebrand factor inducing combined qualitative and quantitative defects in the protein
38. A Novel Single-Domain Antibody Against von Willebrand Factor A1 Domain Resolves Leukocyte Recruitment and Vascular Leakage During Inflammation—Brief Report
39. A murine model to characterize the antithrombotic effect of molecules targeting human von Willebrand factor
40. Of von Willebrand factor and platelets
41. TaSER: Combining forces to stop the clot
42. Macrophage LRP1 contributes to the clearance of von Willebrand factor
43. Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
44. How to keep the factor VIII/von Willebrand factor complex in the circulation
45. Mutation and ADAMTS13-dependent modulation of disease severity in a mouse model for von Willebrand disease type 2B
46. In vivo modulation of a dominant‐negative variant in mouse models of von Willebrand disease type 2A
47. von Willebrand disease: what does the future hold?
48. Anti-inflammatory Activity of the Protein Z-Dependent Protease Inhibitor
49. Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo
50. Altered thrombus formation in von Willebrand factor–deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.